Pet Pharm Biotech Co (ROCO:7762) Scaled Net Operating Assets : 0.65 (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Pet Pharm Biotech Co's operating assets for the quarter that ended in Jun. 2024 was NT$345.2 Mil. Pet Pharm Biotech Co's operating liabilities for the quarter that ended in Jun. 2024 was NT$26.8 Mil. Pet Pharm Biotech Co's Total Assets for the quarter that ended in Dec. 2023 was NT$487.6 Mil. Therefore, Pet Pharm Biotech Co's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.65.

Pet Pharm Biotech Co Scaled Net Operating Assets Historical Data

The historical data trend for Pet Pharm Biotech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co Scaled Net Operating Assets Chart

Pet Pharm Biotech Co Annual Data

Trend

Dec22

Dec23

Scaled Net Operating Assets

0.59

0.82

Pet Pharm Biotech Co Semi-Annual Data
	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	0.59	-	-	0.65

Competitive Comparison of Pet Pharm Biotech Co's Scaled Net Operating Assets

For the Drug Manufacturers - General subindustry, Pet Pharm Biotech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pet Pharm Biotech Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pet Pharm Biotech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Pet Pharm Biotech Co's Scaled Net Operating Assets falls into.

Pet Pharm Biotech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Pet Pharm Biotech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(178.092	-	20.93)	/	191.888
=	0.82

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	487.577	-	309.485
=	178.092

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	73.939	-	41.63	-	11.379
=	20.93

Pet Pharm Biotech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(345.19	-	26.806)	/	487.577
=	0.65

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	662.22	-	317.03
=	345.19

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	174.859	-	39.371	-	108.682
=	26.806

Pet Pharm Biotech Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Pet Pharm Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051

Website

https://www.petpharmbio.com

Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines